• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

氨曲南在新生儿和早产儿中的药代动力学及临床研究

[Pharmacokinetic and clinical studies on aztreonam in neonates and premature infants].

作者信息

Sunakawa K, Ishizuka Y, Saito N, Akita H, Iwata S, Sato Y, Oikawa T

机构信息

Department of Pediatrics, Second Tokyo National Hospital.

出版信息

Jpn J Antibiot. 1990 Mar;43(3):413-23.

PMID:2374294
Abstract

Aztreonam (AZT) was studied for its pharmacokinetics, clinical effect and effect on intestinal bacterial flora in neonates, and the results obtained are summarized as follows: 1. Serum concentrations of AZT upon intravenous administration of 20 mg/kg were 38.6 micrograms/ml in 30 minutes, 30.6 micrograms/ml in 1 hour and 13.6 micrograms/ml in 6 hours. The T 1/2 was 3.73 hours. Ampicillin (ABPC) 25 mg/kg was concurrently used with AZT in 2 cases and serum concentrations of AZT in these 2 cases were 40.3 and 36.9 micrograms/ml in 30 minutes, 35.7 and 32.6 micrograms/ml in 1 hour, and 13.1 and 10.2 micrograms/ml in 6 hours, respectively. T 1/2's were 3.32 and 2.91 hours, respectively, and no interaction between the 2 drugs was observed. 2. AZT was administered to 21 neonates between 0 and 83 days of age and ABPC was concurrently administered to 18 of the cases. Clinical evaluation was made in 14 cases, where AZT was remarkably effective in 7 cases, effective in 6 cases and not effective in 1 case. Of the 21 cases, 1 case of diarrhea, 1 case each of eosinophilia, an increase in platelets, an increase in platelets and an elevation of GOT and a decrease in platelets were recorded. 3. With respect to effects of AZT on intestinal bacterial flora, fecal concentrations of AZT upon its single administration to 2 cases were low suggesting, there was little effect on the intestinal flora. Some effect on anaerobes, however, was recognized in 4 cases in which ABPC was concurrently used.

摘要

对氨曲南(AZT)在新生儿中的药代动力学、临床疗效及对肠道菌群的影响进行了研究,结果总结如下:1. 静脉注射20mg/kg氨曲南后,30分钟时血清浓度为38.6微克/毫升,1小时时为30.6微克/毫升,6小时时为13.6微克/毫升。半衰期为3.73小时。2例同时使用25mg/kg氨苄西林(ABPC)与氨曲南,这2例氨曲南的血清浓度在30分钟时分别为40.3和36.9微克/毫升,1小时时分别为35.7和32.6微克/毫升,6小时时分别为13.1和10.2微克/毫升。半衰期分别为3.32和2.91小时,未观察到两种药物之间的相互作用。2. 对21例年龄在0至83天的新生儿给予氨曲南,其中18例同时给予氨苄西林。对14例进行了临床评估,氨曲南显效7例,有效6例,无效1例。21例中,记录到1例腹泻、1例嗜酸性粒细胞增多、1例血小板增多、1例血小板增多伴谷草转氨酶升高及1例血小板减少。3. 关于氨曲南对肠道菌群的影响,对2例单次给药后氨曲南的粪便浓度较低,提示对肠道菌群影响较小。然而,在4例同时使用氨苄西林的病例中,发现对厌氧菌有一定影响。

相似文献

1
[Pharmacokinetic and clinical studies on aztreonam in neonates and premature infants].氨曲南在新生儿和早产儿中的药代动力学及临床研究
Jpn J Antibiot. 1990 Mar;43(3):413-23.
2
[Pharmacokinetics and clinical studies on aztreonam in neonates and premature infants (the second report). Study on effectiveness and safety in combination therapy using aztreonam and ampicillin. A study of aztreonam in the Perinatal Co-research Group].氨曲南在新生儿和早产儿中的药代动力学及临床研究(第二篇报告)。氨曲南与氨苄西林联合治疗的有效性和安全性研究。围产期联合研究组对氨曲南的一项研究
Jpn J Antibiot. 1990 Mar;43(3):563-78.
3
[Pharmacokinetic and clinical evaluation of aztreonam in neonates and premature infants].氨曲南在新生儿和早产儿中的药代动力学及临床评估
Jpn J Antibiot. 1990 Mar;43(3):425-43.
4
[Pharmacokinetic and clinical evaluations of aztreonam monotherapy and aztreonam and ampicillin combination therapy in neonates and premature infants].氨曲南单药治疗及氨曲南与氨苄西林联合治疗在新生儿和早产儿中的药代动力学及临床评估
Jpn J Antibiot. 1990 Mar;43(3):503-23.
5
[Pharmacokinetics and clinical studies of aztreonam in neonates and premature infants].氨曲南在新生儿和早产儿中的药代动力学及临床研究
Jpn J Antibiot. 1990 Mar;43(3):524-7.
6
[Pharmacokinetics and clinical studies on aztreonam in neonates and premature infants (the first report). Study on effectiveness and safety in mono-therapy with aztreonam. A study of aztreonam in the Perinatal Co-research Group].氨曲南在新生儿和早产儿中的药代动力学及临床研究(首次报告)。氨曲南单药治疗的有效性和安全性研究。围产期联合研究组对氨曲南的一项研究
Jpn J Antibiot. 1990 Mar;43(3):543-62.
7
[Pharmacokinetic, bacteriological and clinical studies on aztreonam in neonates].氨曲南在新生儿中的药代动力学、细菌学及临床研究
Jpn J Antibiot. 1990 Mar;43(3):455-78.
8
[Clinical evaluation of aztreonam in neonatal infections].氨曲南用于新生儿感染的临床评估
Jpn J Antibiot. 1990 Mar;43(3):493-502.
9
[Pharmacokinetic and clinical studies on flomoxef in neonates and premature infants].氟氧头孢在新生儿及早产儿中的药代动力学与临床研究
Jpn J Antibiot. 1991 Nov;44(11):1240-9.
10
[Studies of aztreonam in neonates].[氨曲南在新生儿中的研究]
Jpn J Antibiot. 1990 Mar;43(3):445-54.